Latest Ceo Appointments News

Kingsrose Mining has appointed Andrew Caruso as its new CEO, bringing over three decades of mining leadership experience to drive its Scandinavian projects and acquisition strategy. His remuneration package includes a base salary of CND$400,000 plus performance-linked incentives tied to share price milestones.

Nuix has appointed John Ruthven as its permanent CEO and Managing Director, ending a global search and signalling leadership continuity following his interim role since November 2025.

InteliCare has locked in its largest-ever $8.8 million contract with mecwacare to deploy its AI-driven platform across 22 aged care homes, while appointing Angus Cameron as CEO to spearhead growth.

KGL Resources has secured a US$300 million streaming agreement with Wheaton Precious Metals, unlocking early construction funding for its Jervois Copper-Silver-Gold Project. The updated Baseline Economic Model highlights robust returns with a post-tax NPV8 of A$839 million and a 30% IRR, underpinning the path to production.

Mount Ridley Mines has reported a substantial inferred mineral resource for heavy rare earths and scandium at its Western Australian project, underpinning its multi-element development strategy.

TrivarX has made significant strides in preparing its Stabl-Im stable isotope imaging platform for Phase 1 clinical trials, backed by strengthened leadership and a solid cash reserve of $2.91 million.

Yugo Metals (ASX:YUG) secured government approval for its Petrovo tenement in Bosnia, while initial drilling at Sinjakovo’s Kovacevac and Erak prospects delivered promising polymetallic results. The company also appointed Petar Tomašević as permanent CEO, positioning itself for further exploration progress.

ImpediMed reported a $3.5 million revenue in Q3 FY26, with reimbursement coverage in the US reaching 94.3%, supporting growth in heart health and weight management markets. New CEO Erik Anderson aims to accelerate commercial momentum and drive cash flow break-even.

Woodside Energy posted a solid first quarter with strong asset reliability, an 11% lift in realised prices, and key projects like Scarborough nearing completion. Production dipped due to cyclones but full-year guidance remains steady.

EVE Health Group has begun commercial sales of Libbo, an oral dissolving film for erectile dysfunction, supported by a new digital men’s health platform. The company also expanded its pharmaceutical pipeline and secured $1.3 million in fresh capital to fund ongoing development and commercialization.

Xamble Group stabilised revenue at A$1.64 million in Q1 2026 while narrowing its group EBITDA loss slightly despite ramped-up technology spending. The company completed its acquisition of YouthsToday, tripling its influencer base and locking in three commercial contracts worth A$1.17 million.

Felix Group Holdings reported a 47% surge in total ARR to $12.7 million in Q3 FY26, driven by the Nexvia acquisition and enterprise expansion. The company is progressing AI platform enhancements and completed a key leadership renewal with new Chairman and CEO appointments.